Current Issue: Featured Articles

Sangha
Dermatological Conditions in Skin of Color— Clinical Considerations When Treating Acne Vulgaris in Skin of Color
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S20–S21 by Archana M. Sangha, MMS, PA-C  Ms. Sangha is a medical science liaison for Incyte in Wilmington, Delaware. Prior to that, she spent over a decade as...
RutkowskiNPPA
Potential effects, diagnosis, and management of De Quervain Tenosynovitis in the aesthetics community: A Brief Review, Case Example, and Illustrative Exercises
J Clin Aestet Dermatol 2023;16(9 Suppl 2):S28–S31 by Michele Rutkowski, APrN, FNP-C, and Kristy Rutkowski, OTR/L Ms. M. Rutkowski is with Face Forward Aesthetics in Wexford, Pennsylvania. Ms. K. Rutkowski...
Margaret_Bobonich_headshot-copy
Spotlight Interview: A Deeper Dive into Dermatopathology An Interview with Dr. Maria Robinson
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S41 by Margaret A. Bobonich, DNP, FNP-C, DCNP, FAANP Dr. Bobonich is Assistant Professor at Case Western Reserve University in Cleveland, Ohio, and Founder of...
Maria_Robinson_headshot
Pearls from the Scope— What Your Dermatopathologist Wants You to Know
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S42–S44 by Maria R. Robinson, MD, MBA, FAAD Dr. Robinson is a board-certified dermatologist and dermatopathologist with over 15 years of experience across the...
Devjani
Association Between Atopic Dermatitis, Anxiety, and Symptoms of Panic Among United States Adults in the 2001–2004 National Health and Nutrition Examination Survey
J Clin Aesthet Dermatol. 2023;16(6 Suppl 1):S10–S12 by Shivali Devjani, MS; Brandon Smith, BA; George Han, MD, PhD; and Jashin J. Wu, MD Mr. Devjani is with SUNY Downstate College of Medicine in Brooklyn,...

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.